Literature DB >> 10699181

A new gene involved in DNA double-strand break repair and V(D)J recombination is located on human chromosome 10p.

D Moshous1, L Li, R Chasseval, N Philippe, N Jabado, M J Cowan, A Fischer, J P de Villartay.   

Abstract

V(D)J recombination, accountable for the diversity of T cell receptor- and immunoglobulin-encoding genes, is initiated by a lymphoid-specific DNA double-strand break. The general DNA repair machinery is responsible for the resolution of this break. Any defect in one of the known components of the DNA repair/V(D)J recombination machinery (Ku70, Ku80, DNA-PKcs, XRCC4 and DNA ligase IV) leads to abortion of the V(D)J rearrangement process, early block in both T and B cell maturation, and ultimately to severe combined immune deficiency (SCID) in several animal models. A human SCID condition is also characterized by an absence of mature T and B lymphocytes, and is associated with an increase in sensitivity to DNA-damaging agents (RS-SCID). None of the above-mentioned genes are defective in these patients, arguing for the likelihood of the existence of yet another unknown component of the V(D)J recombination/DNA repair apparatus. Athabascan-speaking (SCIDA) Navajo and Apache Native Americans have a very high incidence of T(-)B(-)SCID. The SCIDA locus is highly linked with markers on chromosome 10p, although the exact molecular defect has not been recognized in these patients. We show here that cells with the SCIDA defect are impaired in the DNA repair phase of V(D)J recombination similarly to RS-SCID, precisely an absence of V(D)J coding joint formation. Moreover, genotyping analysis in several RS-SCID families corroborates a linkage of the RS-SCID locus to the SCIDA region on chromosome 10p. These results demonstrate the presence of a new essential DNA repair/V(D)J recombination gene in this region, the mutation of which causes RS-SCID in humans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10699181     DOI: 10.1093/hmg/9.4.583

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  28 in total

1.  A microsatellite-based multilocus screen for the identification of local selective sweeps.

Authors:  Christian Schlötterer
Journal:  Genetics       Date:  2002-02       Impact factor: 4.562

2.  Artemis is a phosphorylation target of ATM and ATR and is involved in the G2/M DNA damage checkpoint response.

Authors:  Xiaoshan Zhang; Janice Succi; Zhaohui Feng; Sheela Prithivirajsingh; Michael D Story; Randy J Legerski
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

3.  Artemis links ATM to G2/M checkpoint recovery via regulation of Cdk1-cyclin B.

Authors:  Liyi Geng; Xiaoshan Zhang; Shu Zheng; Randy J Legerski
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

4.  Genotype, phenotype, and outcomes of nine patients with T-B+NK+ SCID.

Authors:  Grace P Yu; Kari C Nadeau; David R Berk; Geneviève de Saint Basile; Nathalie Lambert; Perrine Knapnougel; Joseph Roberts; Kristina Kavanau; Elizabeth Dunn; E Richard Stiehm; David B Lewis; Dale T Umetsu; Jennifer M Puck; Morton J Cowan
Journal:  Pediatr Transplant       Date:  2011-08-23

Review 5.  Molecular targets and mechanisms of radiosensitization using DNA damage response pathways.

Authors:  David R Raleigh; Daphne A Haas-Kogan
Journal:  Future Oncol       Date:  2013-02       Impact factor: 3.404

Review 6.  The multifunctional SNM1 gene family: not just nucleases.

Authors:  Yiyi Yan; Shamima Akhter; Xiaoshan Zhang; Randy Legerski
Journal:  Future Oncol       Date:  2010-06       Impact factor: 3.404

Review 7.  Non-homologous end joining often uses microhomology: implications for alternative end joining.

Authors:  Nicholas R Pannunzio; Sicong Li; Go Watanabe; Michael R Lieber
Journal:  DNA Repair (Amst)       Date:  2014-03-07

8.  Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience.

Authors:  William T Shearer; Elizabeth Dunn; Luigi D Notarangelo; Christopher C Dvorak; Jennifer M Puck; Brent R Logan; Linda M Griffith; Donald B Kohn; Richard J O'Reilly; Thomas A Fleisher; Sung-Yun Pai; Caridad A Martinez; Rebecca H Buckley; Morton J Cowan
Journal:  J Allergy Clin Immunol       Date:  2013-11-28       Impact factor: 10.793

9.  Post-transplantation B cell function in different molecular types of SCID.

Authors:  Rebecca H Buckley; Chan M Win; Barry K Moser; Roberta E Parrott; Elisa Sajaroff; Marcella Sarzotti-Kelsoe
Journal:  J Clin Immunol       Date:  2012-09-22       Impact factor: 8.317

10.  Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency.

Authors:  Divya Punwani; Misako Kawahara; Jason Yu; Ukina Sanford; Sushmita Roy; Kiran Patel; Denise A Carbonaro; Andrea D Karlen; Sara Khan; Kenneth Cornetta; Michael Rothe; Axel Schambach; Donald B Kohn; Harry L Malech; R Scott McIvor; Jennifer M Puck; Morton J Cowan
Journal:  Hum Gene Ther       Date:  2016-09-07       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.